CALU and cancer: In contrast, the extracellular CALU isoforms suppressthe signal-regulated kinase 1 and 2 (ERK1/2) signaling and inhibit cell migration.21 These pieces of evidence suggest the potential prognostic and therapeutic values of CALU isoforms in cancers.